Clinical Considerations of Coagulopathy in Acute Liver Failure

作     者：hyoung Kim Bolin Niu Tinsay Woreta Po-Hung Chen Ahyoung Kim;Bolin Niu;Tinsay Woreta;Po-Hung Chen

作者机构：Division of Gastroenterology&HepatologyDepartment of MedicineJohns Hopkins University School of MedicineBaltimoreMDUSA Division of Gastroenterology&HepatologyDepartment of MedicineCase Western Reserve University School of MedicineClevelandOHUSA 

出 版 物：《Journal of Clinical and Translational Hepatology》 (临床与转化肝病杂志（英文版）)

年 卷 期：2020年第8卷第4期

页      面：407-413页

核心收录：

学科分类：1002[医学-临床医学] 10[医学] 

基　　金：This work was supported by the National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health under award number K23AA028297(to PHC)and Johns Hopkins University Clinician Scientist Award(to PHC). 

主　　题：Acute liver failure Coagulopathy Thrombin generation assay Viscoelastic test 

摘      要：Acute liver failure (ALF) is the rapid onset of severe liver dysfunction, defined by the presence of hepatic encephalop-athy and impaired synthetic function (international normal-ized ratio of≥1.5) in the absence of underlying liver disease. The elevated international normalized ratio value in ALF is often misinterpreted as an increased hemorrhagic tendency, which can lead to inappropriate, prophylactic transfusions of blood products. However, global assessments of coagulop-athy via viscoelastic tests or thrombin generation assay suggest a reestablished hemostatic, or even hypercoagu-lable, status in patients with ALF. Although the current versions of global assays are not perfect, they can provide more nuanced insights into the hemostatic system in ALF than the conventional measures of coagulopathy.